Literature DB >> 6206310

The dopamine agonist bromocriptine induces hypotension by venous and arteriolar dilation.

D W Johns, C R Ayers, R M Carey.   

Abstract

Acute bromocriptine administration reduced sitting and standing blood pressure and produced severe orthostatic hypotension in 12 normal subjects. Concomitantly, there was an increase in venous distensibility and basal blood flow, and a decrease in peripheral vascular resistance, as determined by forearm plethysmography. After administration of bromocriptine, plasma norepinephrine concentration decreased. Bromocriptine lowers blood pressure by dilating arterioles and veins, at least in part by means of dopaminergic inhibition of sympathetic nervous system activity.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6206310     DOI: 10.1097/00005344-198407000-00005

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  6 in total

1.  Dopamine receptor type 5 in the primary cilia has dual chemo- and mechano-sensory roles.

Authors:  Shakila Abdul-Majeed; Surya M Nauli
Journal:  Hypertension       Date:  2011-06-27       Impact factor: 10.190

Review 2.  Current pharmacological management of hypotensive syndromes in the elderly.

Authors:  Kannayiram Alagiakrishnan
Journal:  Drugs Aging       Date:  2015-05       Impact factor: 3.923

3.  Bromocriptine in the treatment of hypertension.

Authors:  R J Walden; J Hernandez; P Bhattacharjee; B Graham; B N Prichard
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

4.  Selective peripheral dopamine-1 receptor stimulation with fenoldopam in human essential hypertension.

Authors:  R M Carey; R M Stote; J W Dubb; L H Townsend; C E Rose; D L Kaiser
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808

5.  Association Between Prolactin and Incidence of Cardiovascular Risk Factors in the Framingham Heart Study.

Authors:  Kate E Therkelsen; Tobin M Abraham; Alison Pedley; Joseph M Massaro; Patrice Sutherland; Udo Hoffmann; Caroline S Fox
Journal:  J Am Heart Assoc       Date:  2016-02-23       Impact factor: 5.501

6.  Rotigotine's effect on PLM-associated blood pressure elevations in restless legs syndrome: An RCT.

Authors:  Axel Bauer; Werner Cassel; Heike Benes; Karl Kesper; David Rye; Domenic Sica; John W Winkelman; Lars Bauer; Frank Grieger; Lars Joeres; Kimberly Moran; Erwin Schollmayer; John Whitesides; Hannah C Carney; Arthur S Walters; Wolfgang Oertel; Claudia Trenkwalder
Journal:  Neurology       Date:  2016-04-13       Impact factor: 9.910

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.